With your help, we can help advance medical knowledge and improve the health and well-being of countless others.
Our goal is to assist the pharmaceutical and medical device industries develop new and effective products to treat a multitude of medical conditions and illnesses. We perform this important work through the administration of clinical trials.
Please consider joining us in this effort. Our experienced and professional clinical research staff are highly qualified and fully committed to engaging you and your primary care physician as informed partners in everything we do.
Available Studies
See if you pre-qualify for any of the research studies we are now conducting in your area by following one of the links below.
Investigational Diabetic Peripheral Neuropathy Trial
AMR Chicago Oak Brook is conducting an investigational Type 2 Diabetes trial for participants ages 18 to 75. Qualified participants must have Type 2 Diabetes, a BMI of 27 or greater, be on a stable GLP-1 dose for at least 6 months, and meet other study criteria. Qualified participants will receive all study-related care at no cost. Reimbursement is available up to $2,250.00 for study-related time and travel.
If you are interested in learning more, call AMR today at 800-268-2175 or fill out the form below and a member of our recruitment team will contact you to get started.
Investigational Flu Vaccine Clinical Study
AMR Chicago Oak Brook invites all volunteers ages 50 and older to participate in an investigational flu vaccine clinical research study!
Qualified participants must:
• be ages 50 and older
• have not received any influenza vaccine in the previous 6 months
• meet other study criteria
Qualified participants will receive all study-related care at no cost. Reimbursement is available up to $790.00 for study-related time and travel.
If you are interested in learning more, call AMR today at 800-268-2175 or fill out the form below and a member of our recruitment team will contact you to get started.
Shingles Vaccine Study
Over 99% of people born in the US before 1980 have been exposed to the chickenpox virus, which can become reactivated as you become older, causing shingles.
Shingles is characterized by a painful rash, and complications of HZ can include:
• Lasting nerve pain
• Hearing loss
• Vision loss
Shingles risk increases with age. The CDC recommends that all adults 50+ get vaccinated.
What do I need to know about the study?
• You could get an investigational vaccine or the currently available vaccine, at no cost
• Attend 7 study visits at your local site over 14 months
• You may get compensation for your time and participation
The goal of this study is to study the safety and effect on the immune system of an investigational shingles vaccine, amezosvatein. Some participants will be randomly assigned to receive amezosvatein, and some will receive the currently available vaccine, Shingrix.
Contact AMR Chicago at 888-259-1231 to participate in this clinical research study.
Type 2 Diabetes Clinical Research Study
AMR Chicago Park Ridge is conducting a study to evaluate an investigational medication for those 18 and older with Type 2 Diabetes.
Qualified participants must:
• have a BMI of 27 or greater
• be treating their diabetes with diet and exercise, and/or
• be on a stable oral diabetic medication
• meet other study criteria
Qualified participants will receive all study-related procedures at no cost. Reimbursement is available for study-related time and expenses.
If you’re interested in learning more about this trial, you can reach out to AMR today by calling 800-268-2175 for more detailed information.
Investigational Obesity Study
AMR Chicago Oak Brook is conducting an investigational clinical research study for adults 18 or older with obesity.
Qualified participants must:
• Have a BMI of 35 or greater
• Have tried to lose weight by changing their diet without success
• Have not taken weight loss medication(s) for at least 3 months before the study
• must meet other study criteria
Receive all study-related care and the study medication or placebo at no cost. Compensation is available for study-related time and travel.
If you are interested in learning more, call AMR today at 800-268-2175 or fill out the form below and a member of our recruitment team will contact you to get started.
AMR Chicago Oak Brook is conducting a Clinical Trial of an Investigational Once-Daily ORAL Medication for Type 2 Diabetics with Cardiovascular Risk.
Qualified participants:
• Are 18 and Older
• Have either Heart Disease (incl. heart attack, stent, bypass surgery, heart failure, among others), Peripheral Artery Disease, Kidney Disease, or have had a Stroke or TIA
AND
• Have an A1C of 7 to 10.5 (Stable Treatment of One to Three Oral Medications for Diabetes) Note: If Taking Metformin, ≥1500 mg/day is required.
• Meet Other Study Requirements (Use of Insulin and/or Some Newer Injectable Diabetic Medications is Prohibited)
Reimbursement is available for time and travel.
Contact AMR Chicago Oak Brook at 888-259-1231.
According to the CDC, Atrial Fibrillation, often called AFib or AF, is the most common type of treated heart arrhythmia. An arrhythmia is when the heart beats too slowly, too fast, or in an irregular way. AFib increases your risk of having a stroke due to the formation of blood clots. Oral anticoagulants (sometimes called “blood thinners”) can be used to prevent stroke associated with AFib. AMR Chicago is currently conducting a clinical research study of an investigational treatment to prevent stroke in patients who are diagnosed with AFib but are unsuitable for blood thinners.
Qualified participants must:
• be age 65 or older
• be diagnosed with Afib
• be unsuitable for blood thinners, by your responsible physician(s) or by your own decision
• have conditions associated with a risk of bleeding
• meet other study criteria
Qualified participants will receive at no cost:
• all study-related medical examinations and lab work
• the investigational treatment or placebo
Compensation is available up to $2,700.00 for time and travel. Insurance is not required.
Contact AMR Chicago Park Ridge at 888-259-1231 to participate in this clinical research study.
DO YOU HAVE GENERALISED VITILIGO ON THE FACE AND BODY (for at least 3 months)?
An investigational therapy, afamelanotide, is being evaluated as a treatment for vitiligo patients with darker skin types.
STUDY DURATION: 12 months (Eligibility assessment + 5 months of treatment + 6 months of follow-up)
TWO STUDY TREATMENT GROUPS:
A. Narrowband ultraviolet B (NB-UVB) in combination with afamelanotide
B. NB-UVB alone
You may qualify if you:
• Are aged 12 or more
• Have medium to dark skin
• Do not have extensive white hair in your vitiligo patches
• Do not have a history of melanoma, lentigo maligna or do not have any malignant (cancerous) skin lesions
• Do not have liver diseases
• Are not pregnant or breastfeeding
Participation involves:
• NB-UVB light treatment twice per week for 20 weeks (all participants)
• Receiving an implant of afamelanotide every 3 weeks for 20 weeks (50% of participants)
• Travel costs may be reimbursed
Contact AMR Chicago Oak Brook Terrace at 888-259-1231.
Have you recently been hospitalized because of a Heart Attack?
You may be eligible to participate in a clinical research study evaluating the effects of an investigational drug on reducing the risk of future cardiac/heart events.
You may be eligible to participate if you:
• Are at least 45 years old
• Have had a heart attack within the past 3 months
Eligible patients may receive: • Study-related medical care
To learn more, call AMR Chicago Park Ridge at 888-259-1231 today!
AMR is currently accepting volunteers to participate in an Obesity and Cardiovascular Outcomes clinical research study. Qualified participants are those ages 45 and older who meet other study criteria. Qualified participants will receive all study-related care and the investigational medication or placebo at no cost. Compensation may be available for study-related time and travel.
To learn more, call AMR Chicago Park Ridge at 888-259-1231 today!
AMR is currently accepting volunteers to participate in an Acne clinical research study. Qualified participants are those ages 18 to 45 who meet other study criteria. Qualified participants will receive all study-related care and the investigational treatment or placebo at no cost. Compensation may be available up to $1,400.00 for study-related time and travel.
To learn more, call AMR at 888-259-1231 or complete the form below.
AMR is currently accepting volunteers to participate in an elevated LDL-C clinical research study. Qualified participants are those ages 18 to 75 who meet other study criteria. Qualified participants will receive all study-related care and the investigational medication or placebo at no cost. Reimbursement may be available for time and travel.
To learn more, call AMR at 888-259-1231 or complete the form below.
AMR Chicago Oak Brook is currently enrolling healthy volunteers ages 50 and older in an investigational Shingles vaccine study. Participants must have no history of Shingles, have never received a Shingles vaccine, and meet other study criteria. Receive all study-related care and the investigational vaccine at no cost. Compensation for study-related time and travel is available up to $2,060.00.
If you are interested in learning more, call AMR today at 800-268-2175 or fill out the form below and a member of our recruitment team will contact you to get started.
Frequently Asked Questions
In Phase I trials, researchers test an experimental drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase II trials, the experimental study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase III trials, the experimental study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the experimental drug or treatment to be used safely.
A protocol is a study plan on which all clinical trials are based. The plan is carefully designed to safeguard the health of the participants as well as answer specific research questions. A protocol describes what types of people may participate in the trial; the schedule of tests, procedures, medications, and dosages; and the length of the study. While in a clinical trial, participants following a protocol are seen regularly by the research staff to monitor their health and to determine the safety and effectiveness of their treatment.
Clinical trials that are well-designed and well-executed are the best approach for eligible participants to:
Play an active role in their own health care.
Gain access to new research treatments before they are widely available.
Obtain expert medical care at leading healthcare facilities during the trial.
Help others by contributing to medical research.
Risks
There are risks to clinical trials.
There may be unpleasant, serious or even life-threatening side effects to experimental treatment.
The experimental treatment may not be effective for the participant.
The protocol may require more of their time and attention than would a non-protocol treatment, including trips to the study site, more treatments, hospital stays or complex dosage requirements.
Some clinical trials involve more tests and doctor visits than the participant would normally have for an illness or condition. For all types of trials, the participant works with a research team. Clinical trial participation is most successful when the protocol is carefully followed and there is frequent contact with the research staff.
All clinical trials have guidelines about who can participate. Using inclusion/exclusion criteria is an important principle of medical research that helps to produce reliable results. The factors that allow someone to participate in a clinical trial are called “inclusion criteria” and those that disallow someone from participating are called “exclusion criteria”. These criteria are based on such factors as age, gender, the type and stage of a disease, previous treatment history, and other medical conditions. Before joining a clinical trial, a participant must qualify for the study. Some research studies seek participants with illnesses or conditions to be studied in the clinical trial, while others need healthy participants. It is important to note that inclusion and exclusion criteria are not used to reject people personally. Instead, the criteria are used to identify appropriate participants and keep them safe. The criteria help ensure that researchers will be able to answer the questions they plan to study
Participants in clinical trials can play a more active role in their own health care, gain access to new research treatments before they are widely available, and help others by contributing to medical research.
Although there are many definitions of clinical trials, they are generally considered to be biomedical or health-related research studies in human beings that follow a predefined protocol. ClinicalTrials.gov includes both interventional and observational types of studies. Interventional studies are those in which the research subjects are assigned by the investigator to a treatment or other intervention, and their outcomes are measured. Observational studies are those in which individuals are observed and their outcomes are measured by the investigators.
Volunteer Form
By volunteering for clinical studies, you authorize AMR to store your personal information on file. In accordance with HIPAA regulations, AMR will never share your information with anyone.
Respiratory Syncytial Virus
It is estimated that more than 177,000 older adults are hospitalized and 14,000 of them die in the US due to RSV infections per year. In 2018, more elder Americans died from RSV infection than the common flu.
To learn more, call our enrollment line:
Refer-A-Friend
Earn extra cash* by recommending a friend to us and receive up to $100 for each friend you refer!
Read Important Instructions
* Some restrictions apply. Not all studies are eligible for the Refer-A-Friend program. Ask an AMR representative for details.
Refer-A-Friend
Step 1
Fill out the Refer-A-Friend form. You can download the form here or pick one up at one of our offices. The referrer (you) must fill out the form.
Step 2
Your friend or family member brings the completed referral form to CRC on their first visit to our office and gives it to a staff member upon checking in.
Step 3
If your referral qualifies for and completes all visits for the study, you (the referrer) will earn $100 upon study completion.
